ANIK vs HRL · rev $62.2M vs P/E 29, rev $8.96B
Anika Therapeutics Inc (ANIK) versus Hormel Foods Corporation (HRL) — a side-by-side from cached financials, not a winner call.
Anika Therapeutics Inc (ANIK) is a drug manufacturers - specialty & generic company listed on US.
Hormel Foods Corporation (HRL) is a packaged foods company listed on NYSE.
Latest reported ANIK revenue for 2026-06-30 was $62.2M. Net income was -$1.7M. ANIK currently screens at market cap $161.3M.
Latest reported HRL revenue for 2026-07-26 was $8.96B. Net income was $398.8M. Revenue was up 49.4% from 2026-04-26 to 2026-07-26. HRL currently screens at market cap $13.39B and trailing P/E 28.6.
ANIK currently screens at market cap $161.3M. HRL currently screens at market cap $13.39B and trailing P/E 28.6.
Not investment advice. Open the ANIK and HRL stock pages for the full models.
Not investment advice.